Monara Dini, DPM
Foot & Ankle Surgery · San Francisco, CANPI 1891097655
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,736 of the $15,815 with a category attached, or 80.5%. 39 manufacturers reported payments, led by Epsfl, LLC at 32.7% of the total. Reporting peaked in 2023 at $7,839 and has fallen 87.8% since, to $953 in 2025. Among foot & ankle surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $91.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Epsfl, LLC$5K
- Treace Medical Concepts, Inc.$2K
- Smith+Nephew$2K
- Paragon 28, Inc.$1K
- Voom Medical Devices, Inc.$683
- Stryker$487
- plus $5K from 33 others
What the payments were for
- Travel & lodging$3,03119%
- Food & beverage$12,73681%
- Education$480%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Epsfl, LLC | 2 | $5,170 |
| Treace Medical Concepts, Inc. | 12 | $1,613 |
| Smith+Nephew | 37 | $1,612 |
| Paragon 28, Inc. | 9 | $1,302 |
| Voom Medical Devices, Inc. | 2 | $683 |
| Stryker(2 entities) | 11 | $487 |
| Alafair Biosciences, Inc. | 4 | $453 |
| Osiris Therapeutics Inc. | 9 | $441 |
| Integra Lifesciences Corporation | 8 | $371 |
| Kerecis Limited | 6 | $362 |
| Exactech, Inc. | 2 | $344 |
| Organogenesis Inc. | 3 | $307 |
| Medline Industries LP | 9 | $302 |
| Tactile Systems Technology Inc | 5 | $298 |
| Nevro Corp. | 4 | $223 |
| Orthofix Medical, Inc. | 3 | $207 |
| Curonix LLC | 3 | $162 |
| Crossroads Extremity Systems, LLC | 1 | $152 |
| Derma Sciences, Inc. | 5 | $146 |
| Paratek Pharmaceuticals, Inc. | 6 | $144 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $137 |
| Johnson & Johnson | 3 | $121 |
| Evolution Surgical, Inc | 2 | $113 |
| Bioventus LLC | 3 | $104 |
| Amgen(2 entities) | 3 | $66 |
| Axogen | 2 | $61 |
| Boehringer Ingelheim | 3 | $56 |
| Averitas Pharma Inc. | 2 | $49 |
| Access Pro Medical, LLC | 1 | $47 |
| Urgo Medical North America, LLC | 1 | $39 |
| Bone Support Inc. | 1 | $37 |
| Acell, Inc. | 1 | $37 |
| Aroa Biosurgery Incorporated | 1 | $37 |
| Abbott | 1 | $29 |
| Globus Medical | 1 | $28 |
| Polarityte, Inc. | 1 | $26 |
| Merck | 1 | $17 |
| Zimmer Biomet | 1 | $17 |
| OVIK Health, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,436
- Product Portfolio$1,070
- REVCON$678
- Stravix$465
- Kerecis Omega3 SurgiClose$453
- Grafix$361
- VANTAGE$344
- VersaWrap$294
- GRAFIX PL$278
- PuraPly$269
- PICO$255
- RENASYS GO v2 HOME$255
- GrafixPL$220
- Physio-Stim$158
- AccelStim$158
- Medical Implant$152
- Kerecis Omega3 GraftGuide$151
- Kerecis Omega3 Marigen$151
- Flexitouch Plus$147
- Entre Plus$147
How this compares
$15,815 in reported general payments places this provider in the 90th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 66 | $708 |
| Gabapentin | 38 | $215 |
| Ketoconazole | 11 | $166 |
| Terbinafine Hcl | 13 | $159 |
| Doxycycline Hyclate | 17 | $102 |
| Meloxicam | 30 | $43 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in San Francisco
- Michael CoughlinSan Francisco$1.6M
- Tracey VlahovicSan Francisco$313K
- Charles ParksSan Francisco$225K
- John SchuberthSan Francisco$216K
- Colin TraynorSan Francisco$75K
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.